- Home
- ATMU vs PTGX Comparison
ATMU vs PTGX Comparison
Compare ATMU & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATMU
- PTGX
- Stock Information
- Founded
- ATMU 1958
- PTGX 2006
- Country
- ATMU United States
- PTGX United States
- Employees
- ATMU N/A
- PTGX N/A
- Industry
- ATMU Auto Parts:O.E.M.
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- ATMU Consumer Discretionary
- PTGX Health Care
- Exchange
- ATMU Nasdaq
- PTGX Nasdaq
- Market Cap
- ATMU 2.8B
- PTGX 3.3B
- IPO Year
- ATMU 2023
- PTGX 2016
- Fundamental
- Price
- ATMU $40.04
- PTGX $50.52
- Analyst Decision
- ATMU Buy
- PTGX Strong Buy
- Analyst Count
- ATMU 5
- PTGX 8
- Target Price
- ATMU $42.80
- PTGX $70.13
- AVG Volume (30 Days)
- ATMU 562.8K
- PTGX 619.5K
- Earning Date
- ATMU 08-08-2025
- PTGX 08-06-2025
- Dividend Yield
- ATMU 0.52%
- PTGX N/A
- EPS Growth
- ATMU 13.25
- PTGX N/A
- EPS
- ATMU 2.22
- PTGX 0.80
- Revenue
- ATMU $1,659,500,000.00
- PTGX $209,180,000.00
- Revenue This Year
- ATMU $2.96
- PTGX N/A
- Revenue Next Year
- ATMU $4.71
- PTGX $53.09
- P/E Ratio
- ATMU $17.27
- PTGX $63.34
- Revenue Growth
- ATMU 1.43
- PTGX N/A
- 52 Week Low
- ATMU $30.68
- PTGX $33.31
- 52 Week High
- ATMU $45.43
- PTGX $60.60
- Technical
- Relative Strength Index (RSI)
- ATMU 68.57
- PTGX 37.19
- Support Level
- ATMU $37.22
- PTGX $52.03
- Resistance Level
- ATMU $38.35
- PTGX $54.81
- Average True Range (ATR)
- ATMU 0.90
- PTGX 2.10
- MACD
- ATMU 0.10
- PTGX -0.52
- Stochastic Oscillator
- ATMU 91.36
- PTGX 7.73
About ATMU Atmus Filtration Technologies Inc.
Atmus Filtration Technologies Inc manufactures filtration products for on-highway commercial vehicles and off-highway agriculture, construction, mining, and power generation vehicles and equipment. It designs and manufactures Developed filtration products, principally under the Fleetguard brand, that enable lower emissions and provide asset protection. It designs, manufactures, and sells filters, coolants, and chemical products. The company offers products for first-fit and aftermarket applications including air filters, fuel filters, fuel water separators, lube filters, hydraulic filters, coolants, fuel additives, and other filtration systems to original equipment manufacturers, dealers/distributors, and end-users.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.